受强制性开放获取政策约束的文章 - Amar Natarajan了解详情
无法在其他位置公开访问的文章：2 篇
Protein–protein interactions as therapeutic targets in neuropsychopharmacology.
MT Reilly, KA Cunningham, A Natarajan
Neuropsychopharmacology 34 (1), 2009
强制性开放获取政策： US National Institutes of Health
High-throughput compatible fluorescence resonance energy transfer-based assay to identify small molecule inhibitors of AMSH deubiquitinase activity
JL Arnst, CW Davies, SM Raja, C Das, A Natarajan
Analytical biochemistry 440 (1), 71-77, 2013
强制性开放获取政策： US National Institutes of Health
可在其他位置公开访问的文章：74 篇
Protein tyrosine kinase regulation by ubiquitination: critical roles of Cbl-family ubiquitin ligases
B Mohapatra, G Ahmad, S Nadeau, N Zutshi, W An, S Scheffe, L Dong, ...
Biochimica Et Biophysica Acta (BBA)-Molecular Cell Research 1833 (1), 122-139, 2013
强制性开放获取政策： US National Institutes of Health
Chemically induced degradation of CDK9 by a proteolysis targeting chimera (PROTAC)
CM Robb, JI Contreras, S Kour, MA Taylor, M Abid, YA Sonawane, ...
Chemical communications 53 (54), 7577-7580, 2017
强制性开放获取政策： US National Institutes of Health, US Department of Education
Impact of structurally modifying hyaluronic acid on CD44 interaction
DS Bhattacharya, D Svechkarev, JJ Souchek, TK Hill, MA Taylor, ...
Journal of Materials Chemistry B 5 (41), 8183-8192, 2017
强制性开放获取政策： US National Institutes of Health
Cyclin dependent kinase 9 inhibitors for cancer therapy: miniperspective
YA Sonawane, MA Taylor, JV Napoleon, S Rana, JI Contreras, ...
Journal of medicinal chemistry 59 (19), 8667-8684, 2016
强制性开放获取政策： US National Institutes of Health, US Department of Education
Selective degradation of CDK6 by a palbociclib based PROTAC
S Rana, M Bendjennat, S Kour, HM King, S Kizhake, M Zahid, ...
Bioorganic & medicinal chemistry letters 29 (11), 1375-1379, 2019
强制性开放获取政策： US National Institutes of Health
Isatin derived spirocyclic analogues with α-methylene-γ-butyrolactone as anticancer agents: a structure–activity relationship study
S Rana, EC Blowers, C Tebbe, JI Contreras, P Radhakrishnan, S Kizhake, ...
Journal of medicinal chemistry 59 (10), 5121-5127, 2016
强制性开放获取政策： US National Institutes of Health
Anticancer activity of Celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers
SM Raja, RJ Clubb, C Ortega-Cava, SH Williams, TA Bailey, L Duan, ...
Cancer biology & therapy 11 (2), 263-276, 2011
强制性开放获取政策： US National Institutes of Health
RAC1 GTPase promotes the survival of breast cancer cells in response to hyper-fractionated radiation treatment
AL Hein, CM Post, YM Sheinin, I Lakshmanan, A Natarajan, CA Enke, ...
Oncogene 35 (49), 6319-6329, 2016
强制性开放获取政策： US National Institutes of Health
Small molecule adenosine 5′-monophosphate activated protein kinase (AMPK) modulators and human diseases
S Rana, EC Blowers, A Natarajan
Journal of medicinal chemistry 58 (1), 2-29, 2015
强制性开放获取政策： US National Institutes of Health
Perturbing pro-survival proteins using quinoxaline derivatives: A structure–activity relationship study
R Rajule, VC Bryant, H Lopez, X Luo, A Natarajan
Bioorganic & medicinal chemistry 20 (7), 2227-2234, 2012
强制性开放获取政策： US National Institutes of Health
Human apurinic/apyrimidinic endonuclease (APE1) is acetylated at DNA damage sites in chromatin, and acetylation modulates its DNA repair activity
S Roychoudhury, S Nath, H Song, ML Hegde, LJ Bellot, AK Mantha, ...
Molecular and cellular biology 37 (6), e00401-16, 2017
强制性开放获取政策： US National Institutes of Health
Micellar formulation of indocyanine green for phototherapy of melanoma
V Mundra, Y Peng, S Rana, A Natarajan, RI Mahato
Journal of Controlled Release 220, 130-140, 2015
强制性开放获取政策： US National Institutes of Health
Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders
M Naramura, S Nadeau, B Mohapatra, G Ahmad, C Mukhopadhyay, ...
Oncotarget 2 (3), 245, 2011
强制性开放获取政策： US National Institutes of Health
2, 3-Substituted quinoxalin-6-amine analogs as antiproliferatives: a structure–activity relationship study
Q Chen, VC Bryant, H Lopez, DL Kelly, X Luo, A Natarajan
Bioorganic & medicinal chemistry letters 21 (7), 1929-1932, 2011
强制性开放获取政策： US National Institutes of Health
Dual-fluorophore quantitative high-throughput screen for inhibitors of BRCT–phosphoprotein interaction
A Simeonov, A Yasgar, A Jadhav, GL Lokesh, C Klumpp, S Michael, ...
Analytical biochemistry 375 (1), 60-70, 2008
强制性开放获取政策： US National Institutes of Health
A kinase inhibitor screen reveals protein kinase C-dependent endocytic recycling of ErbB2 in breast cancer cells
TA Bailey, H Luan, E Tom, TA Bielecki, B Mohapatra, G Ahmad, M George, ...
Journal of Biological Chemistry 289 (44), 30443-30458, 2014
强制性开放获取政策： US National Institutes of Health
Inhibition of BRCT (BRCA1)-phosphoprotein interaction enhances the cytotoxic effect of olaparib in breast cancer cells: a proof of concept study for synthetic lethal …
ZY Pessetto, Y Yan, T Bessho, A Natarajan
Breast cancer research and treatment 134, 511-517, 2012
强制性开放获取政策： US National Institutes of Health
Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax
HM King, S Rana, SP Kubica, JR Mallareddy, S Kizhake, EL Ezell, ...
Bioorganic & medicinal chemistry letters 43, 128061, 2021
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定